Brought to you by 
Lombard Medical completes $51.2mm Nasdaq IPO
28 Apr 2014
Executive Summary
UK medical device company Lombard Medical Inc. (LMI; endovascular stent grafts to treat abdominal aortic aneurysms (AAAs)), a shell company formed to conduct the business of Lombard Medical Technologies PLC (LMT), netted $51.2mm in a Nasdaq IPO of 5mm ordinary shares at $11. When Lombard originally filed in March, it had hoped to sell 3.6mm shares at a $15-18 price range. LMT currently trades on London’s AIM market, but plans to delist from that exchange now that the US offer is completed.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Lombard Medical completes $51.2mm Nasdaq IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice